North AmericaBy Timothy M. Squire, Fasken Martineau DuMoulin
On June 18, 2016, the Federal Department of Health published a Notice of Intent to amend the Food and Drug Regulations and the Medical Devices Regulations to implement key authorities under Vanessa’s Law (the “Notice of Intent”).
Vanessa’s Law received royal assent on November 6, 2014, and amended the Food and Drugs Act (the “Act”) by substantially increasing Health Canada’s pre and post-market authority over industry stakeholders and radically changing the consequences for violating the Act and its regulations. Vanessa’s Law introduced the most significant amendments to the Act in 50 years, and represents a new chapter in Canadian drug and medical device regulatory enforcement … (read full article in PDF below)
Tags:
Canada,
Life ScienceChanges are coming!Five factors to consider when reviewing your Canadian trademark strategy in 2019.
Protocol to Amend the Canada-UK Tax TreatyThe Canada-United Kingdom Tax Convention was amended with the signing of a protocol on July 21, 2014. This article will describe some highlights of the Protocol and comment on the impact of these provisions on cross-border tax issues between Canada and the ...
The Canadian insurance M&A environmentThere have been a significant number of insurance company M&A transactions in the Canadian market in recent years, a trend expected to continue. Fasken Martineau DuMoulin have surveyed the acquisition agreements from these transactions and analysed ...
Related Articles by Jurisdiction
Global economic weatherThe balance of good news vs bad news about the global economy reached its most positive point since November 2015 during this week ...